nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—ADRB1—coronary artery disease	0.149	0.543	CbGaD
Betaxolol—ADRB2—coronary artery disease	0.126	0.457	CbGaD
Betaxolol—Oxprenolol—Penbutolol—coronary artery disease	0.103	0.391	CrCrCtD
Betaxolol—Alprenolol—Penbutolol—coronary artery disease	0.103	0.391	CrCrCtD
Betaxolol—Propranolol—Penbutolol—coronary artery disease	0.0575	0.218	CrCrCtD
Betaxolol—ADRB2—Penbutolol—coronary artery disease	0.0535	0.189	CbGbCtD
Betaxolol—ADRB1—Penbutolol—coronary artery disease	0.0527	0.186	CbGbCtD
Betaxolol—ADRB2—Timolol—coronary artery disease	0.0377	0.133	CbGbCtD
Betaxolol—ADRB1—Timolol—coronary artery disease	0.0371	0.131	CbGbCtD
Betaxolol—CYP1A2—Gemfibrozil—coronary artery disease	0.0188	0.0664	CbGbCtD
Betaxolol—CYP1A2—Clopidogrel—coronary artery disease	0.0163	0.0576	CbGbCtD
Betaxolol—CYP2D6—Niacin—coronary artery disease	0.0102	0.036	CbGbCtD
Betaxolol—CYP2D6—Timolol—coronary artery disease	0.00945	0.0334	CbGbCtD
Betaxolol—CYP2D6—Captopril—coronary artery disease	0.00832	0.0294	CbGbCtD
Betaxolol—CYP2D6—Simvastatin—coronary artery disease	0.00804	0.0284	CbGbCtD
Betaxolol—CYP1A2—Losartan—coronary artery disease	0.00795	0.0281	CbGbCtD
Betaxolol—CYP2D6—Lovastatin—coronary artery disease	0.00786	0.0278	CbGbCtD
Betaxolol—CYP2D6—Pravastatin—coronary artery disease	0.00786	0.0278	CbGbCtD
Betaxolol—CYP2D6—Atorvastatin—coronary artery disease	0.00716	0.0253	CbGbCtD
Betaxolol—Practolol—ADRB1—coronary artery disease	0.000263	0.0935	CrCbGaD
Betaxolol—Esmolol—ADRB1—coronary artery disease	0.000189	0.0672	CrCbGaD
Betaxolol—Atenolol—ADRB1—coronary artery disease	0.000165	0.0586	CrCbGaD
Betaxolol—Bisoprolol—ADRB1—coronary artery disease	0.000161	0.0571	CrCbGaD
Betaxolol—Esmolol—ADRB2—coronary artery disease	0.000159	0.0565	CrCbGaD
Betaxolol—Acebutolol—ADRB1—coronary artery disease	0.000152	0.0541	CrCbGaD
Betaxolol—Oxprenolol—ADRB1—coronary artery disease	0.000151	0.0537	CrCbGaD
Betaxolol—Atenolol—ADRB2—coronary artery disease	0.000139	0.0493	CrCbGaD
Betaxolol—Alprenolol—ADRB1—coronary artery disease	0.000138	0.0491	CrCbGaD
Betaxolol—Bisoprolol—ADRB2—coronary artery disease	0.000135	0.048	CrCbGaD
Betaxolol—Metoprolol—ADRB1—coronary artery disease	0.000129	0.0457	CrCbGaD
Betaxolol—Acebutolol—ADRB2—coronary artery disease	0.000128	0.0455	CrCbGaD
Betaxolol—Oxprenolol—ADRB2—coronary artery disease	0.000127	0.0452	CrCbGaD
Betaxolol—Pindolol—ADRB1—coronary artery disease	0.000119	0.0423	CrCbGaD
Betaxolol—Alprenolol—ADRB2—coronary artery disease	0.000116	0.0413	CrCbGaD
Betaxolol—Metoprolol—ADRB2—coronary artery disease	0.000108	0.0384	CrCbGaD
Betaxolol—Pindolol—ADRB2—coronary artery disease	0.0001	0.0355	CrCbGaD
Betaxolol—Metoprolol—CYP2C19—coronary artery disease	9.31e-05	0.0331	CrCbGaD
Betaxolol—Chlorphenesin—PTGS2—coronary artery disease	7.44e-05	0.0264	CrCbGaD
Betaxolol—Propranolol—ADRB1—coronary artery disease	6.49e-05	0.0231	CrCbGaD
Betaxolol—Propranolol—ADRB2—coronary artery disease	5.46e-05	0.0194	CrCbGaD
Betaxolol—Propranolol—CYP2C19—coronary artery disease	4.7e-05	0.0167	CrCbGaD
Betaxolol—Arthralgia—Timolol—coronary artery disease	2.78e-05	0.000197	CcSEcCtD
Betaxolol—Chest pain—Timolol—coronary artery disease	2.78e-05	0.000197	CcSEcCtD
Betaxolol—Myalgia—Timolol—coronary artery disease	2.78e-05	0.000197	CcSEcCtD
Betaxolol—Vomiting—Ezetimibe—coronary artery disease	2.77e-05	0.000197	CcSEcCtD
Betaxolol—Hypersensitivity—Pravastatin—coronary artery disease	2.77e-05	0.000197	CcSEcCtD
Betaxolol—Anxiety—Timolol—coronary artery disease	2.77e-05	0.000197	CcSEcCtD
Betaxolol—Pruritus—Olmesartan—coronary artery disease	2.77e-05	0.000197	CcSEcCtD
Betaxolol—Decreased appetite—Losartan—coronary artery disease	2.76e-05	0.000196	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	2.76e-05	0.000196	CcSEcCtD
Betaxolol—Body temperature increased—Captopril—coronary artery disease	2.76e-05	0.000196	CcSEcCtD
Betaxolol—Dizziness—Simvastatin—coronary artery disease	2.75e-05	0.000195	CcSEcCtD
Betaxolol—Rash—Ezetimibe—coronary artery disease	2.75e-05	0.000195	CcSEcCtD
Betaxolol—Dermatitis—Ezetimibe—coronary artery disease	2.75e-05	0.000195	CcSEcCtD
Betaxolol—Confusional state—Ramipril—coronary artery disease	2.75e-05	0.000195	CcSEcCtD
Betaxolol—Discomfort—Timolol—coronary artery disease	2.75e-05	0.000195	CcSEcCtD
Betaxolol—Asthenia—Niacin—coronary artery disease	2.74e-05	0.000195	CcSEcCtD
Betaxolol—Fatigue—Losartan—coronary artery disease	2.74e-05	0.000195	CcSEcCtD
Betaxolol—Headache—Ezetimibe—coronary artery disease	2.73e-05	0.000194	CcSEcCtD
Betaxolol—Malaise—Lisinopril—coronary artery disease	2.73e-05	0.000194	CcSEcCtD
Betaxolol—Oedema—Ramipril—coronary artery disease	2.72e-05	0.000194	CcSEcCtD
Betaxolol—Vertigo—Lisinopril—coronary artery disease	2.72e-05	0.000193	CcSEcCtD
Betaxolol—Dry mouth—Timolol—coronary artery disease	2.72e-05	0.000193	CcSEcCtD
Betaxolol—Pain—Losartan—coronary artery disease	2.72e-05	0.000193	CcSEcCtD
Betaxolol—Constipation—Losartan—coronary artery disease	2.72e-05	0.000193	CcSEcCtD
Betaxolol—Syncope—Lisinopril—coronary artery disease	2.72e-05	0.000193	CcSEcCtD
Betaxolol—Vomiting—Eplerenone—coronary artery disease	2.72e-05	0.000193	CcSEcCtD
Betaxolol—Feeling abnormal—Furosemide—coronary artery disease	2.71e-05	0.000193	CcSEcCtD
Betaxolol—Nausea—Fenofibrate—coronary artery disease	2.71e-05	0.000192	CcSEcCtD
Betaxolol—Pruritus—Niacin—coronary artery disease	2.7e-05	0.000192	CcSEcCtD
Betaxolol—Asthenia—Pravastatin—coronary artery disease	2.7e-05	0.000192	CcSEcCtD
Betaxolol—Rash—Eplerenone—coronary artery disease	2.69e-05	0.000191	CcSEcCtD
Betaxolol—Urticaria—Perindopril—coronary artery disease	2.69e-05	0.000191	CcSEcCtD
Betaxolol—Hypersensitivity—Trandolapril—coronary artery disease	2.69e-05	0.000191	CcSEcCtD
Betaxolol—Dermatitis—Eplerenone—coronary artery disease	2.69e-05	0.000191	CcSEcCtD
Betaxolol—Diarrhoea—Valsartan—coronary artery disease	2.69e-05	0.000191	CcSEcCtD
Betaxolol—Confusional state—Timolol—coronary artery disease	2.69e-05	0.000191	CcSEcCtD
Betaxolol—Shock—Ramipril—coronary artery disease	2.68e-05	0.00019	CcSEcCtD
Betaxolol—Hypersensitivity—Enalapril—coronary artery disease	2.68e-05	0.00019	CcSEcCtD
Betaxolol—Body temperature increased—Perindopril—coronary artery disease	2.68e-05	0.00019	CcSEcCtD
Betaxolol—Palpitations—Lisinopril—coronary artery disease	2.68e-05	0.00019	CcSEcCtD
Betaxolol—Diarrhoea—Olmesartan—coronary artery disease	2.68e-05	0.00019	CcSEcCtD
Betaxolol—Headache—Eplerenone—coronary artery disease	2.68e-05	0.00019	CcSEcCtD
Betaxolol—Nervous system disorder—Ramipril—coronary artery disease	2.67e-05	0.00019	CcSEcCtD
Betaxolol—Thrombocytopenia—Ramipril—coronary artery disease	2.67e-05	0.00019	CcSEcCtD
Betaxolol—Oedema—Timolol—coronary artery disease	2.66e-05	0.000189	CcSEcCtD
Betaxolol—Pruritus—Pravastatin—coronary artery disease	2.66e-05	0.000189	CcSEcCtD
Betaxolol—Loss of consciousness—Lisinopril—coronary artery disease	2.66e-05	0.000189	CcSEcCtD
Betaxolol—Nausea—Clopidogrel—coronary artery disease	2.66e-05	0.000189	CcSEcCtD
Betaxolol—Tachycardia—Ramipril—coronary artery disease	2.66e-05	0.000189	CcSEcCtD
Betaxolol—Skin disorder—Ramipril—coronary artery disease	2.65e-05	0.000188	CcSEcCtD
Betaxolol—Infection—Timolol—coronary artery disease	2.65e-05	0.000188	CcSEcCtD
Betaxolol—Vomiting—Simvastatin—coronary artery disease	2.65e-05	0.000188	CcSEcCtD
Betaxolol—Hypersensitivity—Telmisartan—coronary artery disease	2.64e-05	0.000188	CcSEcCtD
Betaxolol—Cough—Lisinopril—coronary artery disease	2.64e-05	0.000188	CcSEcCtD
Betaxolol—Nausea—Lovastatin—coronary artery disease	2.64e-05	0.000188	CcSEcCtD
Betaxolol—Hyperhidrosis—Ramipril—coronary artery disease	2.63e-05	0.000187	CcSEcCtD
Betaxolol—Rash—Simvastatin—coronary artery disease	2.62e-05	0.000186	CcSEcCtD
Betaxolol—Dermatitis—Simvastatin—coronary artery disease	2.62e-05	0.000186	CcSEcCtD
Betaxolol—Asthenia—Trandolapril—coronary artery disease	2.62e-05	0.000186	CcSEcCtD
Betaxolol—Shock—Timolol—coronary artery disease	2.62e-05	0.000186	CcSEcCtD
Betaxolol—Feeling abnormal—Losartan—coronary artery disease	2.62e-05	0.000186	CcSEcCtD
Betaxolol—Urticaria—Furosemide—coronary artery disease	2.62e-05	0.000186	CcSEcCtD
Betaxolol—Diarrhoea—Niacin—coronary artery disease	2.61e-05	0.000186	CcSEcCtD
Betaxolol—Nervous system disorder—Timolol—coronary artery disease	2.61e-05	0.000186	CcSEcCtD
Betaxolol—Asthenia—Enalapril—coronary artery disease	2.61e-05	0.000185	CcSEcCtD
Betaxolol—Headache—Simvastatin—coronary artery disease	2.61e-05	0.000185	CcSEcCtD
Betaxolol—Body temperature increased—Furosemide—coronary artery disease	2.6e-05	0.000185	CcSEcCtD
Betaxolol—Dizziness—Valsartan—coronary artery disease	2.6e-05	0.000185	CcSEcCtD
Betaxolol—Anorexia—Ramipril—coronary artery disease	2.6e-05	0.000185	CcSEcCtD
Betaxolol—Nausea—Ezetimibe—coronary artery disease	2.59e-05	0.000184	CcSEcCtD
Betaxolol—Skin disorder—Timolol—coronary artery disease	2.59e-05	0.000184	CcSEcCtD
Betaxolol—Dizziness—Olmesartan—coronary artery disease	2.59e-05	0.000184	CcSEcCtD
Betaxolol—Pruritus—Trandolapril—coronary artery disease	2.58e-05	0.000184	CcSEcCtD
Betaxolol—Myalgia—Lisinopril—coronary artery disease	2.58e-05	0.000183	CcSEcCtD
Betaxolol—Arthralgia—Lisinopril—coronary artery disease	2.58e-05	0.000183	CcSEcCtD
Betaxolol—Chest pain—Lisinopril—coronary artery disease	2.58e-05	0.000183	CcSEcCtD
Betaxolol—Hyperhidrosis—Timolol—coronary artery disease	2.58e-05	0.000183	CcSEcCtD
Betaxolol—Asthenia—Telmisartan—coronary artery disease	2.57e-05	0.000183	CcSEcCtD
Betaxolol—Pruritus—Enalapril—coronary artery disease	2.57e-05	0.000183	CcSEcCtD
Betaxolol—Diarrhoea—Pravastatin—coronary artery disease	2.57e-05	0.000183	CcSEcCtD
Betaxolol—Anxiety—Lisinopril—coronary artery disease	2.57e-05	0.000183	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.56e-05	0.000182	CcSEcCtD
Betaxolol—Discomfort—Lisinopril—coronary artery disease	2.55e-05	0.000181	CcSEcCtD
Betaxolol—Hypotension—Ramipril—coronary artery disease	2.55e-05	0.000181	CcSEcCtD
Betaxolol—Anorexia—Timolol—coronary artery disease	2.54e-05	0.00018	CcSEcCtD
Betaxolol—Pruritus—Telmisartan—coronary artery disease	2.54e-05	0.00018	CcSEcCtD
Betaxolol—Nausea—Eplerenone—coronary artery disease	2.54e-05	0.00018	CcSEcCtD
Betaxolol—Dizziness—Niacin—coronary artery disease	2.53e-05	0.000179	CcSEcCtD
Betaxolol—Urticaria—Losartan—coronary artery disease	2.52e-05	0.000179	CcSEcCtD
Betaxolol—Dry mouth—Lisinopril—coronary artery disease	2.52e-05	0.000179	CcSEcCtD
Betaxolol—Body temperature increased—Losartan—coronary artery disease	2.51e-05	0.000178	CcSEcCtD
Betaxolol—Asthenia—Captopril—coronary artery disease	2.5e-05	0.000178	CcSEcCtD
Betaxolol—Diarrhoea—Trandolapril—coronary artery disease	2.5e-05	0.000178	CcSEcCtD
Betaxolol—Vomiting—Valsartan—coronary artery disease	2.5e-05	0.000177	CcSEcCtD
Betaxolol—Confusional state—Lisinopril—coronary artery disease	2.49e-05	0.000177	CcSEcCtD
Betaxolol—Diarrhoea—Enalapril—coronary artery disease	2.49e-05	0.000177	CcSEcCtD
Betaxolol—Hypotension—Timolol—coronary artery disease	2.49e-05	0.000177	CcSEcCtD
Betaxolol—Dizziness—Pravastatin—coronary artery disease	2.49e-05	0.000177	CcSEcCtD
Betaxolol—Vomiting—Olmesartan—coronary artery disease	2.49e-05	0.000177	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.48e-05	0.000176	CcSEcCtD
Betaxolol—Rash—Valsartan—coronary artery disease	2.48e-05	0.000176	CcSEcCtD
Betaxolol—Dermatitis—Valsartan—coronary artery disease	2.48e-05	0.000176	CcSEcCtD
Betaxolol—Nausea—Simvastatin—coronary artery disease	2.47e-05	0.000176	CcSEcCtD
Betaxolol—Oedema—Lisinopril—coronary artery disease	2.47e-05	0.000176	CcSEcCtD
Betaxolol—Pruritus—Captopril—coronary artery disease	2.47e-05	0.000175	CcSEcCtD
Betaxolol—Rash—Olmesartan—coronary artery disease	2.47e-05	0.000175	CcSEcCtD
Betaxolol—Insomnia—Ramipril—coronary artery disease	2.46e-05	0.000175	CcSEcCtD
Betaxolol—Dermatitis—Olmesartan—coronary artery disease	2.46e-05	0.000175	CcSEcCtD
Betaxolol—Headache—Valsartan—coronary artery disease	2.46e-05	0.000175	CcSEcCtD
Betaxolol—Diarrhoea—Telmisartan—coronary artery disease	2.46e-05	0.000174	CcSEcCtD
Betaxolol—Infection—Lisinopril—coronary artery disease	2.46e-05	0.000174	CcSEcCtD
Betaxolol—Headache—Olmesartan—coronary artery disease	2.45e-05	0.000174	CcSEcCtD
Betaxolol—Paraesthesia—Ramipril—coronary artery disease	2.45e-05	0.000174	CcSEcCtD
Betaxolol—Shock—Lisinopril—coronary artery disease	2.43e-05	0.000173	CcSEcCtD
Betaxolol—Asthenia—Perindopril—coronary artery disease	2.43e-05	0.000173	CcSEcCtD
Betaxolol—Dyspnoea—Ramipril—coronary artery disease	2.43e-05	0.000173	CcSEcCtD
Betaxolol—Vomiting—Niacin—coronary artery disease	2.43e-05	0.000173	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Timolol—coronary artery disease	2.43e-05	0.000172	CcSEcCtD
Betaxolol—Hypersensitivity—Furosemide—coronary artery disease	2.43e-05	0.000172	CcSEcCtD
Betaxolol—Thrombocytopenia—Lisinopril—coronary artery disease	2.42e-05	0.000172	CcSEcCtD
Betaxolol—Dizziness—Trandolapril—coronary artery disease	2.42e-05	0.000172	CcSEcCtD
Betaxolol—Tachycardia—Lisinopril—coronary artery disease	2.41e-05	0.000171	CcSEcCtD
Betaxolol—Insomnia—Timolol—coronary artery disease	2.41e-05	0.000171	CcSEcCtD
Betaxolol—Rash—Niacin—coronary artery disease	2.41e-05	0.000171	CcSEcCtD
Betaxolol—Dermatitis—Niacin—coronary artery disease	2.41e-05	0.000171	CcSEcCtD
Betaxolol—Dizziness—Enalapril—coronary artery disease	2.41e-05	0.000171	CcSEcCtD
Betaxolol—Skin disorder—Lisinopril—coronary artery disease	2.4e-05	0.000171	CcSEcCtD
Betaxolol—Dyspepsia—Ramipril—coronary artery disease	2.4e-05	0.00017	CcSEcCtD
Betaxolol—Pruritus—Perindopril—coronary artery disease	2.4e-05	0.00017	CcSEcCtD
Betaxolol—Headache—Niacin—coronary artery disease	2.39e-05	0.00017	CcSEcCtD
Betaxolol—Paraesthesia—Timolol—coronary artery disease	2.39e-05	0.00017	CcSEcCtD
Betaxolol—Vomiting—Pravastatin—coronary artery disease	2.39e-05	0.00017	CcSEcCtD
Betaxolol—Hyperhidrosis—Lisinopril—coronary artery disease	2.39e-05	0.00017	CcSEcCtD
Betaxolol—Diarrhoea—Captopril—coronary artery disease	2.39e-05	0.00017	CcSEcCtD
Betaxolol—Dyspnoea—Timolol—coronary artery disease	2.37e-05	0.000169	CcSEcCtD
Betaxolol—Dizziness—Telmisartan—coronary artery disease	2.37e-05	0.000169	CcSEcCtD
Betaxolol—Rash—Pravastatin—coronary artery disease	2.37e-05	0.000169	CcSEcCtD
Betaxolol—Dermatitis—Pravastatin—coronary artery disease	2.37e-05	0.000168	CcSEcCtD
Betaxolol—Decreased appetite—Ramipril—coronary artery disease	2.37e-05	0.000168	CcSEcCtD
Betaxolol—Asthenia—Furosemide—coronary artery disease	2.36e-05	0.000168	CcSEcCtD
Betaxolol—Headache—Pravastatin—coronary artery disease	2.36e-05	0.000167	CcSEcCtD
Betaxolol—Anorexia—Lisinopril—coronary artery disease	2.36e-05	0.000167	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Ramipril—coronary artery disease	2.35e-05	0.000167	CcSEcCtD
Betaxolol—Fatigue—Ramipril—coronary artery disease	2.35e-05	0.000167	CcSEcCtD
Betaxolol—Dyspepsia—Timolol—coronary artery disease	2.34e-05	0.000167	CcSEcCtD
Betaxolol—Hypersensitivity—Losartan—coronary artery disease	2.34e-05	0.000166	CcSEcCtD
Betaxolol—Nausea—Valsartan—coronary artery disease	2.33e-05	0.000166	CcSEcCtD
Betaxolol—Pruritus—Furosemide—coronary artery disease	2.33e-05	0.000166	CcSEcCtD
Betaxolol—Constipation—Ramipril—coronary artery disease	2.33e-05	0.000166	CcSEcCtD
Betaxolol—Nausea—Olmesartan—coronary artery disease	2.32e-05	0.000165	CcSEcCtD
Betaxolol—Vomiting—Trandolapril—coronary artery disease	2.32e-05	0.000165	CcSEcCtD
Betaxolol—Diarrhoea—Perindopril—coronary artery disease	2.32e-05	0.000165	CcSEcCtD
Betaxolol—Decreased appetite—Timolol—coronary artery disease	2.32e-05	0.000165	CcSEcCtD
Betaxolol—Vomiting—Enalapril—coronary artery disease	2.31e-05	0.000164	CcSEcCtD
Betaxolol—Hypotension—Lisinopril—coronary artery disease	2.31e-05	0.000164	CcSEcCtD
Betaxolol—Dizziness—Captopril—coronary artery disease	2.31e-05	0.000164	CcSEcCtD
Betaxolol—Rash—Trandolapril—coronary artery disease	2.3e-05	0.000164	CcSEcCtD
Betaxolol—Dermatitis—Trandolapril—coronary artery disease	2.3e-05	0.000163	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Timolol—coronary artery disease	2.3e-05	0.000163	CcSEcCtD
Betaxolol—Fatigue—Timolol—coronary artery disease	2.3e-05	0.000163	CcSEcCtD
Betaxolol—Rash—Enalapril—coronary artery disease	2.29e-05	0.000163	CcSEcCtD
Betaxolol—Dermatitis—Enalapril—coronary artery disease	2.29e-05	0.000163	CcSEcCtD
Betaxolol—Headache—Trandolapril—coronary artery disease	2.29e-05	0.000163	CcSEcCtD
Betaxolol—Vomiting—Telmisartan—coronary artery disease	2.28e-05	0.000162	CcSEcCtD
Betaxolol—Asthenia—Losartan—coronary artery disease	2.28e-05	0.000162	CcSEcCtD
Betaxolol—Headache—Enalapril—coronary artery disease	2.28e-05	0.000162	CcSEcCtD
Betaxolol—Pain—Timolol—coronary artery disease	2.28e-05	0.000162	CcSEcCtD
Betaxolol—Nausea—Niacin—coronary artery disease	2.27e-05	0.000161	CcSEcCtD
Betaxolol—Rash—Telmisartan—coronary artery disease	2.26e-05	0.000161	CcSEcCtD
Betaxolol—Dermatitis—Telmisartan—coronary artery disease	2.26e-05	0.000161	CcSEcCtD
Betaxolol—Diarrhoea—Furosemide—coronary artery disease	2.25e-05	0.00016	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.25e-05	0.00016	CcSEcCtD
Betaxolol—Pruritus—Losartan—coronary artery disease	2.25e-05	0.00016	CcSEcCtD
Betaxolol—Headache—Telmisartan—coronary artery disease	2.25e-05	0.00016	CcSEcCtD
Betaxolol—Feeling abnormal—Ramipril—coronary artery disease	2.25e-05	0.00016	CcSEcCtD
Betaxolol—Dizziness—Perindopril—coronary artery disease	2.24e-05	0.000159	CcSEcCtD
Betaxolol—Insomnia—Lisinopril—coronary artery disease	2.24e-05	0.000159	CcSEcCtD
Betaxolol—Nausea—Pravastatin—coronary artery disease	2.23e-05	0.000159	CcSEcCtD
Betaxolol—Paraesthesia—Lisinopril—coronary artery disease	2.22e-05	0.000158	CcSEcCtD
Betaxolol—Vomiting—Captopril—coronary artery disease	2.22e-05	0.000158	CcSEcCtD
Betaxolol—Dyspnoea—Lisinopril—coronary artery disease	2.2e-05	0.000157	CcSEcCtD
Betaxolol—Rash—Captopril—coronary artery disease	2.2e-05	0.000156	CcSEcCtD
Betaxolol—Dermatitis—Captopril—coronary artery disease	2.2e-05	0.000156	CcSEcCtD
Betaxolol—Feeling abnormal—Timolol—coronary artery disease	2.2e-05	0.000156	CcSEcCtD
Betaxolol—Headache—Captopril—coronary artery disease	2.19e-05	0.000155	CcSEcCtD
Betaxolol—Dizziness—Furosemide—coronary artery disease	2.18e-05	0.000155	CcSEcCtD
Betaxolol—Dyspepsia—Lisinopril—coronary artery disease	2.18e-05	0.000155	CcSEcCtD
Betaxolol—Diarrhoea—Losartan—coronary artery disease	2.17e-05	0.000154	CcSEcCtD
Betaxolol—Nausea—Trandolapril—coronary artery disease	2.17e-05	0.000154	CcSEcCtD
Betaxolol—Urticaria—Ramipril—coronary artery disease	2.16e-05	0.000154	CcSEcCtD
Betaxolol—Nausea—Enalapril—coronary artery disease	2.16e-05	0.000154	CcSEcCtD
Betaxolol—Vomiting—Perindopril—coronary artery disease	2.15e-05	0.000153	CcSEcCtD
Betaxolol—Body temperature increased—Ramipril—coronary artery disease	2.15e-05	0.000153	CcSEcCtD
Betaxolol—Decreased appetite—Lisinopril—coronary artery disease	2.15e-05	0.000153	CcSEcCtD
Betaxolol—Rash—Perindopril—coronary artery disease	2.14e-05	0.000152	CcSEcCtD
Betaxolol—Dermatitis—Perindopril—coronary artery disease	2.13e-05	0.000152	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.13e-05	0.000152	CcSEcCtD
Betaxolol—Nausea—Telmisartan—coronary artery disease	2.13e-05	0.000151	CcSEcCtD
Betaxolol—Fatigue—Lisinopril—coronary artery disease	2.13e-05	0.000151	CcSEcCtD
Betaxolol—Headache—Perindopril—coronary artery disease	2.12e-05	0.000151	CcSEcCtD
Betaxolol—Urticaria—Timolol—coronary artery disease	2.12e-05	0.00015	CcSEcCtD
Betaxolol—Pain—Lisinopril—coronary artery disease	2.11e-05	0.00015	CcSEcCtD
Betaxolol—Constipation—Lisinopril—coronary artery disease	2.11e-05	0.00015	CcSEcCtD
Betaxolol—Body temperature increased—Timolol—coronary artery disease	2.11e-05	0.00015	CcSEcCtD
Betaxolol—Dizziness—Losartan—coronary artery disease	2.1e-05	0.000149	CcSEcCtD
Betaxolol—Vomiting—Furosemide—coronary artery disease	2.09e-05	0.000149	CcSEcCtD
Betaxolol—Rash—Furosemide—coronary artery disease	2.08e-05	0.000148	CcSEcCtD
Betaxolol—Dermatitis—Furosemide—coronary artery disease	2.07e-05	0.000147	CcSEcCtD
Betaxolol—Nausea—Captopril—coronary artery disease	2.07e-05	0.000147	CcSEcCtD
Betaxolol—Headache—Furosemide—coronary artery disease	2.06e-05	0.000147	CcSEcCtD
Betaxolol—Feeling abnormal—Lisinopril—coronary artery disease	2.04e-05	0.000145	CcSEcCtD
Betaxolol—Vomiting—Losartan—coronary artery disease	2.02e-05	0.000144	CcSEcCtD
Betaxolol—Nausea—Perindopril—coronary artery disease	2.01e-05	0.000143	CcSEcCtD
Betaxolol—Hypersensitivity—Ramipril—coronary artery disease	2.01e-05	0.000143	CcSEcCtD
Betaxolol—Rash—Losartan—coronary artery disease	2e-05	0.000142	CcSEcCtD
Betaxolol—Dermatitis—Losartan—coronary artery disease	2e-05	0.000142	CcSEcCtD
Betaxolol—Headache—Losartan—coronary artery disease	1.99e-05	0.000141	CcSEcCtD
Betaxolol—Urticaria—Lisinopril—coronary artery disease	1.96e-05	0.000139	CcSEcCtD
Betaxolol—Hypersensitivity—Timolol—coronary artery disease	1.96e-05	0.000139	CcSEcCtD
Betaxolol—Nausea—Furosemide—coronary artery disease	1.96e-05	0.000139	CcSEcCtD
Betaxolol—Asthenia—Ramipril—coronary artery disease	1.96e-05	0.000139	CcSEcCtD
Betaxolol—Body temperature increased—Lisinopril—coronary artery disease	1.95e-05	0.000139	CcSEcCtD
Betaxolol—Pruritus—Ramipril—coronary artery disease	1.93e-05	0.000137	CcSEcCtD
Betaxolol—Asthenia—Timolol—coronary artery disease	1.91e-05	0.000136	CcSEcCtD
Betaxolol—Nausea—Losartan—coronary artery disease	1.89e-05	0.000134	CcSEcCtD
Betaxolol—Pruritus—Timolol—coronary artery disease	1.88e-05	0.000134	CcSEcCtD
Betaxolol—Diarrhoea—Ramipril—coronary artery disease	1.86e-05	0.000132	CcSEcCtD
Betaxolol—Diarrhoea—Timolol—coronary artery disease	1.82e-05	0.000129	CcSEcCtD
Betaxolol—Hypersensitivity—Lisinopril—coronary artery disease	1.82e-05	0.000129	CcSEcCtD
Betaxolol—Dizziness—Ramipril—coronary artery disease	1.8e-05	0.000128	CcSEcCtD
Betaxolol—Asthenia—Lisinopril—coronary artery disease	1.77e-05	0.000126	CcSEcCtD
Betaxolol—Dizziness—Timolol—coronary artery disease	1.76e-05	0.000125	CcSEcCtD
Betaxolol—Pruritus—Lisinopril—coronary artery disease	1.75e-05	0.000124	CcSEcCtD
Betaxolol—Vomiting—Ramipril—coronary artery disease	1.73e-05	0.000123	CcSEcCtD
Betaxolol—Rash—Ramipril—coronary artery disease	1.72e-05	0.000122	CcSEcCtD
Betaxolol—Dermatitis—Ramipril—coronary artery disease	1.72e-05	0.000122	CcSEcCtD
Betaxolol—Headache—Ramipril—coronary artery disease	1.71e-05	0.000121	CcSEcCtD
Betaxolol—Vomiting—Timolol—coronary artery disease	1.69e-05	0.00012	CcSEcCtD
Betaxolol—Diarrhoea—Lisinopril—coronary artery disease	1.69e-05	0.00012	CcSEcCtD
Betaxolol—Rash—Timolol—coronary artery disease	1.68e-05	0.000119	CcSEcCtD
Betaxolol—Dermatitis—Timolol—coronary artery disease	1.68e-05	0.000119	CcSEcCtD
Betaxolol—Headache—Timolol—coronary artery disease	1.67e-05	0.000119	CcSEcCtD
Betaxolol—Dizziness—Lisinopril—coronary artery disease	1.63e-05	0.000116	CcSEcCtD
Betaxolol—Nausea—Ramipril—coronary artery disease	1.62e-05	0.000115	CcSEcCtD
Betaxolol—Nausea—Timolol—coronary artery disease	1.58e-05	0.000112	CcSEcCtD
Betaxolol—Vomiting—Lisinopril—coronary artery disease	1.57e-05	0.000112	CcSEcCtD
Betaxolol—Rash—Lisinopril—coronary artery disease	1.56e-05	0.000111	CcSEcCtD
Betaxolol—Dermatitis—Lisinopril—coronary artery disease	1.56e-05	0.000111	CcSEcCtD
Betaxolol—Headache—Lisinopril—coronary artery disease	1.55e-05	0.00011	CcSEcCtD
Betaxolol—Nausea—Lisinopril—coronary artery disease	1.47e-05	0.000104	CcSEcCtD
Betaxolol—CYP2D6—Metabolism—APOA5—coronary artery disease	5.46e-06	0.000155	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	5.44e-06	0.000154	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC22A3—coronary artery disease	5.42e-06	0.000153	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	5.37e-06	0.000152	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	5.36e-06	0.000152	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—P4HB—coronary artery disease	5.36e-06	0.000152	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	5.36e-06	0.000152	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	5.34e-06	0.000151	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HADH—coronary artery disease	5.34e-06	0.000151	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ARNTL—coronary artery disease	5.34e-06	0.000151	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	5.29e-06	0.00015	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	5.26e-06	0.000149	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	5.25e-06	0.000149	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	5.25e-06	0.000149	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	5.25e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	5.24e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	5.23e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	5.23e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	5.23e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	5.17e-06	0.000146	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	5.13e-06	0.000145	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	5.11e-06	0.000145	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	5.11e-06	0.000145	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	5.11e-06	0.000145	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	5.11e-06	0.000145	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA2—coronary artery disease	5.06e-06	0.000143	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	5.06e-06	0.000143	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPX2—coronary artery disease	5.06e-06	0.000143	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SULT1A1—coronary artery disease	5e-06	0.000141	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HK1—coronary artery disease	5e-06	0.000141	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPX4—coronary artery disease	5e-06	0.000141	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCG5—coronary artery disease	5e-06	0.000141	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	5e-06	0.000141	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	5e-06	0.000141	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	4.99e-06	0.000141	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—VCAN—coronary artery disease	4.96e-06	0.00014	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HADHA—coronary artery disease	4.94e-06	0.00014	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	4.94e-06	0.00014	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALDOA—coronary artery disease	4.92e-06	0.000139	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	4.9e-06	0.000139	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTA1—coronary artery disease	4.88e-06	0.000138	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	4.87e-06	0.000138	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	4.86e-06	0.000137	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	4.83e-06	0.000137	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPA—coronary artery disease	4.83e-06	0.000137	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	4.82e-06	0.000136	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	4.79e-06	0.000135	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—DCN—coronary artery disease	4.77e-06	0.000135	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	4.76e-06	0.000135	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	4.75e-06	0.000134	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	4.75e-06	0.000134	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	4.75e-06	0.000134	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	4.72e-06	0.000133	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	4.71e-06	0.000133	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLCB3—coronary artery disease	4.67e-06	0.000132	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	4.67e-06	0.000132	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	4.67e-06	0.000132	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	4.65e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	4.65e-06	0.000131	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALDH2—coronary artery disease	4.64e-06	0.000131	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA5—coronary artery disease	4.63e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	4.61e-06	0.00013	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	4.57e-06	0.000129	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	4.57e-06	0.000129	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	4.55e-06	0.000129	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—P4HB—coronary artery disease	4.54e-06	0.000128	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LIPC—coronary artery disease	4.53e-06	0.000128	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP2C19—coronary artery disease	4.53e-06	0.000128	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	4.53e-06	0.000128	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HBA1—coronary artery disease	4.53e-06	0.000128	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOC3—coronary artery disease	4.5e-06	0.000127	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.5e-06	0.000127	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LDLR—coronary artery disease	4.47e-06	0.000126	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	4.45e-06	0.000126	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	4.45e-06	0.000126	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	4.45e-06	0.000126	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	4.42e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC9A1—coronary artery disease	4.42e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTT1—coronary artery disease	4.42e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.4e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCLC—coronary artery disease	4.37e-06	0.000124	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CETP—coronary artery disease	4.37e-06	0.000124	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.35e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	4.35e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	4.34e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	4.33e-06	0.000122	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SDC1—coronary artery disease	4.32e-06	0.000122	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	4.25e-06	0.00012	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	4.25e-06	0.00012	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—C3—coronary artery disease	4.25e-06	0.00012	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—VCAN—coronary artery disease	4.2e-06	0.000119	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALDOA—coronary artery disease	4.17e-06	0.000118	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	4.16e-06	0.000118	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—C3—coronary artery disease	4.15e-06	0.000117	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.08e-06	0.000115	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PSMB5—coronary artery disease	4.08e-06	0.000115	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	4.05e-06	0.000115	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—DCN—coronary artery disease	4.04e-06	0.000114	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	4.03e-06	0.000114	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CTGF—coronary artery disease	3.99e-06	0.000113	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	3.96e-06	0.000112	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	3.95e-06	0.000112	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	3.95e-06	0.000112	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.95e-06	0.000112	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GOT2—coronary artery disease	3.95e-06	0.000112	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	3.95e-06	0.000112	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALDH2—coronary artery disease	3.93e-06	0.000111	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	3.91e-06	0.000111	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	3.87e-06	0.00011	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	3.87e-06	0.000109	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	3.87e-06	0.000109	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	3.85e-06	0.000109	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.84e-06	0.000109	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	3.83e-06	0.000108	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2C19—coronary artery disease	3.83e-06	0.000108	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HBA1—coronary artery disease	3.83e-06	0.000108	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LIPC—coronary artery disease	3.83e-06	0.000108	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	3.82e-06	0.000108	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOC3—coronary artery disease	3.81e-06	0.000108	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LDLR—coronary artery disease	3.79e-06	0.000107	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	3.79e-06	0.000107	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.78e-06	0.000107	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	3.77e-06	0.000107	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	3.76e-06	0.000106	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTT1—coronary artery disease	3.74e-06	0.000106	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC9A1—coronary artery disease	3.74e-06	0.000106	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—F2—coronary artery disease	3.73e-06	0.000105	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	3.73e-06	0.000105	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	3.71e-06	0.000105	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CETP—coronary artery disease	3.7e-06	0.000105	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCLC—coronary artery disease	3.7e-06	0.000105	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	3.69e-06	0.000104	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	3.68e-06	0.000104	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SDC1—coronary artery disease	3.66e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—F2—coronary artery disease	3.65e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	3.65e-06	0.000103	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.63e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	3.63e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	3.6e-06	0.000102	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	3.57e-06	0.000101	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.52e-06	9.96e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	3.49e-06	9.87e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.46e-06	9.78e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.46e-06	9.78e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.45e-06	9.76e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	3.42e-06	9.68e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GGT1—coronary artery disease	3.41e-06	9.65e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GOT1—coronary artery disease	3.41e-06	9.65e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	3.4e-06	9.61e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	3.4e-06	9.61e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CTGF—coronary artery disease	3.38e-06	9.55e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	3.35e-06	9.47e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GOT2—coronary artery disease	3.35e-06	9.47e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.35e-06	9.47e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	3.32e-06	9.4e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	3.32e-06	9.4e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	3.32e-06	9.4e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	3.31e-06	9.37e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	3.27e-06	9.24e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	3.25e-06	9.2e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	3.25e-06	9.19e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	3.24e-06	9.17e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	3.19e-06	9.04e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	3.18e-06	9e-05	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.11e-06	8.79e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	3.1e-06	8.77e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.08e-06	8.7e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.06e-06	8.66e-05	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	3.04e-06	8.6e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.03e-06	8.58e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	3.03e-06	8.58e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.02e-06	8.54e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.02e-06	8.54e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	3e-06	8.49e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.98e-06	8.44e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CAT—coronary artery disease	2.98e-06	8.43e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	2.96e-06	8.38e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	2.94e-06	8.31e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	2.9e-06	8.19e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOB—coronary artery disease	2.89e-06	8.18e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GGT1—coronary artery disease	2.89e-06	8.17e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GOT1—coronary artery disease	2.89e-06	8.17e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	2.88e-06	8.14e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	2.82e-06	7.98e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	2.81e-06	7.96e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.81e-06	7.96e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPL—coronary artery disease	2.76e-06	7.82e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	2.76e-06	7.81e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GPX1—coronary artery disease	2.69e-06	7.62e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	2.63e-06	7.43e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CD36—coronary artery disease	2.62e-06	7.43e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.59e-06	7.34e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.59e-06	7.33e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.57e-06	7.27e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	2.57e-06	7.27e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.56e-06	7.24e-05	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	2.54e-06	7.18e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CAT—coronary artery disease	2.52e-06	7.14e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	2.51e-06	7.11e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	2.5e-06	7.07e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.49e-06	7.04e-05	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	2.48e-06	7.02e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	2.46e-06	6.96e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOB—coronary artery disease	2.45e-06	6.93e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	2.45e-06	6.92e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	2.44e-06	6.91e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	2.39e-06	6.77e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.38e-06	6.74e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	2.38e-06	6.72e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AGT—coronary artery disease	2.36e-06	6.69e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPL—coronary artery disease	2.34e-06	6.62e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	2.32e-06	6.57e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOE—coronary artery disease	2.32e-06	6.55e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	2.3e-06	6.52e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA1—coronary artery disease	2.29e-06	6.48e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPX1—coronary artery disease	2.28e-06	6.46e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	2.25e-06	6.38e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CD36—coronary artery disease	2.22e-06	6.29e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.2e-06	6.21e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	2.13e-06	6.04e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.11e-06	5.96e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	2.09e-06	5.9e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—coronary artery disease	2.02e-06	5.71e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AGT—coronary artery disease	2e-06	5.66e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—POMC—coronary artery disease	1.99e-06	5.63e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOE—coronary artery disease	1.96e-06	5.55e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.96e-06	5.54e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA1—coronary artery disease	1.94e-06	5.49e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.92e-06	5.43e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.92e-06	5.42e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.88e-06	5.31e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.86e-06	5.25e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—coronary artery disease	1.81e-06	5.13e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NOS3—coronary artery disease	1.73e-06	4.91e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—coronary artery disease	1.71e-06	4.83e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—POMC—coronary artery disease	1.68e-06	4.77e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.67e-06	4.71e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.63e-06	4.61e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.59e-06	4.49e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—coronary artery disease	1.54e-06	4.35e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	1.48e-06	4.17e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NOS3—coronary artery disease	1.47e-06	4.16e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	1.44e-06	4.08e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	1.36e-06	3.85e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.34e-06	3.8e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	1.33e-06	3.77e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	9.76e-07	2.76e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CA—coronary artery disease	8.27e-07	2.34e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—coronary artery disease	7.97e-07	2.26e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—coronary artery disease	6.75e-07	1.91e-05	CbGpPWpGaD
